AUTHOR=Pinilla-Fernández Irene , Ríos-León Marta , Deelchand Dinesh Kumar , Garrido Leoncio , Torres-Llacsa Mabel , García-García Fernando , Vidorreta Marta , Ip I. Betina , Bridge Holly , Taylor Julian , Barriga-Martín Andrés 

TITLE=Chronic neuropathic pain components in whiplash-associated disorders correlate with metabolite concentrations in the anterior cingulate and dorsolateral prefrontal cortex: a consensus-driven MRS re-examination

JOURNAL=Frontiers in Medicine

VOLUME=11

YEAR=2024

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1404939

DOI=10.3389/fmed.2024.1404939

ISSN=2296-858X

ABSTRACT=<sec id="sec1"><title>Introduction</title><p>Whiplash injury (WHI) is characterised by a forced neck flexion/extension, which frequently occurs after motor vehicle collisions. Previous studies characterising differences in brain metabolite concentrations and correlations with neuropathic pain (NP) components with chronic whiplash-associated disorders (WAD) have been demonstrated in affective pain-processing areas such as the anterior cingulate cortex (ACC). However, the detection of a difference in metabolite concentrations within these cortical areas with chronic WAD pain has been elusive. In this study, single-voxel magnetic resonance spectroscopy (MRS), following the latest MRSinMRS consensus group guidelines, was performed in the anterior cingulate cortex (ACC), left dorsolateral prefrontal cortex (DLPFC), and occipital cortex (OCC) to quantify differences in metabolite concentrations in individuals with chronic WAD with or without neuropathic pain (NP) components.</p></sec><sec id="sec2"><title>Materials and methods</title><p>Healthy individuals (<italic>n</italic> = 29) and participants with chronic WAD (<italic>n</italic> = 29) were screened with the Douleur Neuropathique 4 Questionnaire (DN4) and divided into groups without (WAD-noNP, <italic>n</italic> = 15) or with NP components (WAD-NP, <italic>n</italic> = 14). Metabolites were quantified with LCModel following a single session in a 3 T MRI scanner within the ACC, DLPFC, and OCC.</p></sec><sec id="sec3"><title>Results</title><p>Participants with WAD-NP presented moderate pain intensity and interference compared with the WAD-noNP group. Single-voxel MRS analysis demonstrated a higher glutamate concentration in the ACC and lower total choline (tCho) in the DLPFC in the WAD-NP versus WAD-noNP group, with no intergroup metabolite difference detected in the OCC. Best fit and stepwise multiple regression revealed that the normalised ACC glutamate/total creatine (tCr) (<italic>p</italic> = 0.01), DLPFC n-acetyl-aspartate (NAA)/tCr (<italic>p</italic> = 0.001), and DLPFC tCho/tCr levels (<italic>p</italic> = 0.02) predicted NP components in the WAD-NP group (ACC <italic>r</italic><sup>2</sup> = 0.26, α = 0.81; DLPFC <italic>r</italic><sup>2</sup> = 0.62, α = 0.98). The normalised Glu/tCr concentration was higher in the healthy than the WAD-noNP group within the ACC (<italic>p</italic> &lt; 0.05), but not in the DLPFC or OCC. Neither sex nor age affected key normalised metabolite concentrations related to WAD-NP components when compared to the WAD-noNP group.</p></sec><sec id="sec4"><title>Discussion</title><p>This study demonstrates that elevated glutamate concentrations within the ACC are related to chronic WAD-NP components, while higher NAA and lower tCho metabolite levels suggest a role for increased neuronal–glial signalling and cell membrane dysfunction in individuals with chronic WAD-NP components.</p></sec>